BULL, FUTU rise premarket after earnings-linked news flow
BULL and FUTU are up 10% premarket on earnings-related news, while DE gains 4% on earnings and RARE rises 6% on U.S. FDA approval of GENGLYCOS gene therapy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.